Board of Directors
Executive Directors
Mr. Tsoi Hoi Shan (Chairman)
Mr. Leung Wing Hon (Vice-Chairman)
Ms. Choy Siu Chit
Mr. Fang Yu Ping
Ms. Zou Xian Hong
Ms. Zhu Su Yan
Independent Non-Executive Directors
Mr. Chong Peng Oon
Prof. Song Ming
Dr. Fu Qiushi
Senior Management
Mr. Wu Shou Ting
Mr. Zhang Wen Yu
Mr. Han Yu Bo
Mr. Liu Hong Chi
Mr. Zheng Shun Teng
Mr. Zhang Yu Bin
Mr. Cao Chun Lai
Board of Directors
Executive Directors
Mr. Tsoi Hoi Shan ( 蔡 海 山 ) is an executive director and the Chairman of the Company. Mr. Tsoi joined the Group in 2000 as a supervisor of the quality control department and was responsible for supervising the production process at the Hong Kong Yuen Long Plant and ensuring that it was in compliance with the Good Manufacturing Practice. Mr. Tsoi graduated from Tongji Medical University with a bachelor degree in pharmacy in 1998. Mr. Tsoi is the brother of Ms. Choy Siu Chit, who is an executive director of the Company.
Mr. Leung Wing Hon ( 梁 永 康 ) is an executive director, the Vice-Chairman, the Chief Financial Officer and the Company Secretary of the Company. Mr. Leung is a fellow member of the Hong Kong Instituteof Certified Public Accountants, a fellow member of the Association of International Accountants and a fellow member of The Taxation Institute of Hong Kong. He holds a Bachelor of Accountancy degree from University of Bolton and Postgraduate Certificate in Business Administration from University of Leicester in the United Kingdom. Mr. Leung has over 30 years' experience in accounting, finance management and business administration. Mr. Leung joined the Group in 1997 and is responsible for overseeing the financial matters of the Group.
Ms. Choy Siu Chit ( 蔡 紹 哲 ) is an executive director of the Company. Ms. Choy joined the Group in 1990. She handled the Drug Master File submission relating to the Group's amoxicillin bulk medicine with the FDA pursuant to which the Group became the holder of Drug Master File Type II (no. DMF 15377) relating to its amoxicillin bulk medicine in 2001. Ms. Choy also holds directorship in certain subsidiaries of the Company. She passed the Private Equity Investment Fund Advanced Class organized by the Beijing University with distinction in 2010. Ms. Choy is a director of Mighty Brokerage (Asia) Limited, which principally provides brokerage and securities trading services in Hong Kong. She is the sister of Mr. Tsoi Hoi Shan, an executive director and the Chairman of the Company.
Mr. Fang Yu Ping ( 方 煜 平 ) is an executive director of the Company and a vice president of the Group. Mr. Fang graduated from the Medical School of Southeast University in the PRC, with a bachelor degree in medicine in 1986. After graduation, he served as a teaching staff member of the School for 8 years. Mr. Fang joined the Group in 1995 and was promoted to vice president of the Group in 2008. He was the general manager of China Sales Division of Finished Products from 2011 to 2018.
Ms. Zou Xian Hong ( 鄒 鮮 紅 ) is an executive director of the Company and a vice president of the Group. Ms. Zou graduated from China Pharmaceutical University in 1984 and obtained her Executive Master of Business Administration from Hunan University in 2005. In June 2010, Ms. Zou obtained a doctorate in management science of Central South University. Ms. Zou has over 30 years' experience in the PRC pharmaceutical industry. Ms. Zou was employed as a teacher at the Hunan Medical Middle School from 1988 to 1993 prior to joining the Group in 1994. Since joining the Group, she has been responsible for the sales management of the Group. She was the general manager of China Sales Division of Finished Products from 2008 to 2010.
Ms. Zhu Su Yan ( 朱 蘇 燕 ) is an executive director of the Company and a vice president of the Group. Ms. Zhu graduated from Southeast University in the PRC in 1988. She was granted a degree of Executive Master of Business Administration from Business School of Nanjing University in 2005. Ms. Zhu worked in Nanjing Gulou Hospital as a neurosurgeon from 1988 to 1993, and joined Pfizer in 1994. She joined the Group in early 1995 and had served as regional manager of Jiangsu Province, vice president of national hospital development department and general manager of China Sales Division of Finished Products etc. Ms. Zhu has extensive experience in the sales and marketing of pharmaceutical products in the PRC and is principally responsible for the sales and marketing of the Group's products in the PRC.
Independent Non-Executive Directors
Mr. Chong Peng Oon ( 張 品 文 ) was appointed as an independent non-executive director on 31 March 2009. He is the chairman of the audit committee, remuneration committee and risk management committee, and a member of the nomination committee of the Company. Mr. Chong was admitted as an Associate of the Institute of Chartered Accountant in England & Wales in April 1975 and was recognised as a Fellow Member of the Institute in 1981. He was in the accounting practice in Hong Kong for over 30 years. He has experience in auditing of companies ranging from small and medium enterprises to large listed groups in the service and other sectors including shipping, logistics, electronics and real estate. Mr. Chong retired from the accounting practice on 1 January 2009 and now acts as a consultant specialised in cross-border business and tax advisory business for companies in Hong Kong and China. He was a former member of the Foreign Experts Group for Independent Auditing Standards Committee of the Chinese Institute of Certified Public Accountants.
Prof. Song Ming ( 宋 敏 ) was appointed as an independent non-executive Director on 25 May 2007. He is the chairman of the nomination committee and a member of the audit committee, remuneration committee and Risk Management Committee of the Company. Prof. Song graduated from the Department of Economics of the Ohio State University in 1991 and obtained a PhD, majoring in financial economics. Prof. Song is currently Dean of Economics and Management School of Wuhan University. Prof. Song is also an independent non-executive director of Great Wall Pan Asia Holdings Limited (Stock Code: 583) and Guotai Junan International Holdings Limited (Stock Code: 1788), both are listed on the main board of the Stock Exchange of Hong Kong and an independent director of Tande Co., Ltd., a company listed on the Shanghai Stock Exchange.
Dr. Fu Qiu Shi (傅 秋 實), was appointed as an independent non-executive director on 30 June 2023. He is a member of the audit committee, remuneration committee and nomination committee of the Company. Dr. Fu obtained a master degree in life sciences from Peking University in 1997 and a Doctor of Philosophy degree from the University of Illinois in 2004. He has over 15 years of experience in investment management by acting as a partner of various venture capital institutions specialising in the investment in healthcare and biopharmaceutical industries. Dr. Fu started his venture capital career in July 2007 with Fortune Venture Capital Co., Ltd., mainly responsible for the investment in the healthcare industry. Dr. Fu is currently a partner of Shanghai Lichen Private Equity Management Co., Ltd.
Senior Management
Mr. Wu Shou Ting ( 吳 守 廷 ) is the general manager of the Group's Zhuhai United Laboratories Co., Ltd. (Zhongshan Branch). Mr. Wu graduated from Jiangxi College of Chinese Medicine in 1990 and graduated from the Advanced Level Research Class, Selected Course of the MBA for Managers in Office of Zhongshan University in 2002. Mr. Wu was employed by Yufeng Pharmaceutical, Nanchang City, Jiangxi Province for approximately three years before joining the Group in 1996. He had worked as supervisor of the powder injection workshop and manager of the production department at the Group's production plant in Zhongshan before being promoted to general manager in September 2003. Mr. Wu is primarily responsible for the overall management and operation of the Group's production plant in Zhongshan.
Mr. Zhang Wen Yu ( 張 文 玉 ) is the general manager of United Laboratories (Inner Mongolia) Limited. Mr. Zhang graduated from school of microbiology of Shandong University. Mr. Zhang joined the Group in 2005 and had over 15 years' experience in the field of production management and is currently responsible for the management of the Group's Inner Mongolia factory.
Mr. Han Yu Bo ( 韓 玉 波 ) is the general manager of Zhuhai United Laboratories Co., Ltd. Mr. Han graduated from East China University of Science and Technology in 1994. He has over 20 years' experience in pharmacy production management. Mr. Han joined the Group in 2005 and has worked in United Laboratories (Chengdu) and United Laboratories (Inner Mongolia). He is currently responsible for management of the Group's production plant in Zhuhai.
Mr. Liu Hong Chi ( 劉 紅 池 ) is the general manager of The United Animal Healthcare (Inner Mongolia) Co., Ltd. of the Group. Mr. Liu graduated from Sichuan University of Science and Engineering in 2004 majoring in pharmaceutical manufacturing. He obtained a bachelor degree in veterinary medicine from Sichuan Agricultural University in 2017 and a master degree in business administration from Sichuan University in 2019. Mr. Liu joined the Group in 2004, and has worked in United Laboratories (Chengdu) and United Laboratories (Inner Mongolia). He has been responsible for the management of animal healthcare company of the Group in Inner Mongolia since 2014.
Mr. Zheng Shun Teng ( 鄭 順 騰 ) is the operating senior general manager of the Group's intermediate and bulk medicine. Mr. Zheng graduated from China Pharmaceutical University majoring in Pharmacy in 2002, and graduated from the Advanced Level Research Class, Selected Course of the MBA for Managers in Office of Sun Yat-sen University in 2002. Joining in 1997, he worked successively as the head of the orally-taken solid workshop, the assistant to manager of the production department, the manager of the procurement department, and the director of the powder injection workshop of Zhongshan factory. From July 2006 to 2013, he had been the Eastern China regional manager and senior regional manager of the Group's intermediate and bulk medicine sales department, the sales director of the Eastern China region and the Southern China region, and the sales director of the regions of India, Middle East and Africa. Mr. Zheng has been the operating general manager of the Group's intermediate and bulk medicine sales department since 2014 and was promoted to senior general manager and assistant to executive director in 2022, primarily responsible for overall sales operation and management of the Group's intermediate and bulk medicine.
Mr. Zhang Yu Bin (張 玉 斌) is the general manager of the Group's Finished Products Marketing Center. Mr. Zhang obtained a bachelor degree in Chinese language and literature education from West China Normal University in 1995 and an executive master's degree in business administration from Southwestern University of Finance and Economics in 2011. Mr. Zhang joined the Group in 1998 and has over 25 years of experience in pharmaceutical sales and marketing. He has been responsible for sales operations in multiple provinces and served as sales representative, supervisor, regional manager, general regional manager, deputy general manager, vice president, etc. He was previously responsible for sales management in Sichuan, Hunan, Guizhou, Gansu and Qinghai. Mr. Zhang has served as the general manager of the Finished Products Marketing Center since 15 December 2024.
Mr. Cao Chun Lai ( 曹 春 來 ) is the general manager of United Bio-Technology (Hengqin) Co., Ltd. Mr. Cao obtained a master degree in fermentation engineering from South China University of Technology in 2005, and joined the Group in the same year. He was the director of the Biological Research Institute of Zhuhai United Laboratories Co., Ltd. and the director of the Guangdong Diabetes Biopharmaceutical Engineering Technology Center. He has been engaged in R&D of recombinant protein drugs especially diabetic drugs for 18 years.
updated 16th December, 2024
| © Copyright 1996-2024 irasia.com Ltd. All rights reserved. |
|
DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any
information provided on this website. Under no circumstances shall irasia.com Ltd be liable
for damages resulting from the use of the information provided on this website.
TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website. |